MACQUARIE GROUP LTD - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 285 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$58,159,012
-3.4%
3,759,498
-1.9%
0.07%
+5.8%
Q2 2023$60,181,090
-6.6%
3,830,755
-2.0%
0.07%
-10.4%
Q1 2023$64,416,339
+7.6%
3,908,735
+1.9%
0.08%
+8.5%
Q4 2022$59,841,054
+15.5%
3,835,990
-4.0%
0.07%
+10.9%
Q3 2022$51,803,000
-9.3%
3,994,044
-1.8%
0.06%0.0%
Q2 2022$57,115,000
-5.5%
4,067,990
-3.6%
0.06%
+39.1%
Q1 2022$60,451,000
+18.5%
4,221,381
+12.8%
0.05%
+7.0%
Q4 2021$51,018,000
-33.7%
3,743,125
-20.3%
0.04%
-34.8%
Q3 2021$76,938,000
-3.6%
4,697,123
-0.9%
0.07%0.0%
Q2 2021$79,786,000
+1.6%
4,740,712
+10.2%
0.07%
-40.5%
Q1 2021$78,541,000
+1.2%
4,301,275
+0.9%
0.11%
-1.8%
Q4 2020$77,619,000
+9.5%
4,264,775
+7.3%
0.11%
-5.8%
Q3 2020$70,909,000
-5.7%
3,974,738
-5.3%
0.12%
-7.7%
Q2 2020$75,218,000
-1.7%
4,195,081
-16.8%
0.13%
-17.2%
Q1 2020$76,504,000
-24.1%
5,039,797
-1.4%
0.16%
+9.0%
Q4 2019$100,809,000
+10.6%
5,109,419
-3.6%
0.14%
-5.9%
Q3 2019$91,171,000
-68.8%
5,300,636
-67.9%
0.15%
-7.8%
Q2 2019$292,374,000
+200.2%
16,518,309
+245.5%
0.17%0.0%
Q1 2019$97,395,0004,781,2680.17%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q1 2022
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,903,662$29,449,6525.37%
MANAGED ASSET PORTFOLIOS, LLC 1,736,416$26,862,3564.12%
Y.D. More Investments Ltd 1,381,550$21,372,5794.11%
Clean Yield Group 533,157$8,167,9653.62%
XY Capital Ltd 143,697$2,222,9931.28%
Mondrian Investment Partners LTD 4,081,715$61,225,7251.26%
Capricorn Fund Managers Ltd 204,892$3,169,6791.10%
Legacy Wealth Asset Management, LLC 124,967$1,933,2390.71%
HAP Trading, LLC 263,679$4,079,1140.65%
BRANDES INVESTMENT PARTNERS, LP 1,802,036$27,877,4930.54%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders